Bentham Science Logo

Track Your Manuscript:


Current Drug Targets

Volume 21, 16 Issues, 2020
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

Current Drug Targets, Volume 11 - Number 11




Hematological Targets of Radiation Damage

, 11(11): 1375 - 1385

Shilpa Kulkarni, Sanchita P. Ghosh, Martin Hauer-Jensen and K. Sree Kumar


DOI: 10.2174/1389450111009011375









Effects of Cissampelos sympodialis Eichl. and its Alkaloid, Warifteine, in an Experimental Model of Respiratory Allergy to Blomia tropicalis

, 11(11): 1458 - 1467

Ana Tereza Cerqueira-Lima, Neuza Maria Alcantara-Neves, Lain Carlos Pontes de Carvalho, Ryan Santos Costa, Jose Maria Barbosa-Filho, Marcia Piuvezam, Momtchilo Russo, Renato Barboza, Eduardo de Jesus Oliveira, Alexsandro Marinho and Camila Alexandrina Figueiredo


DOI: 10.2174/1389450111009011458




Editor-in-Chief

Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)
View Full Editorial Board

COPE Compliant

Journal History

Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 2.63

Advertisement

Covid Resource Center

Related Journals

Related eBooks

eBooks Catalog